Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy Individuals
Status unconfirmed · Not applicable
Conditions studied: Dry Eye Syndromes, Age-Related Macular Degeneration, Omega 3 Index
In brief
The purpose of this study is to determine increases in the Omega Index test indicating optimal Omega-3s particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) levels for overall systemic benefits including healthy cardiovascular health and cholesterol levels as shown in the OmegaIndex (OmegaQuant) research.
Key facts
- Study ID
- NCT05763940
- Run by
- Western University of Health Sciences
- People needed
- 130
- Starts
- 2022-05-25
- Expected to finish
- 2024-06-25
- Last updated by the study team
- 2024-04-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- not currently taking Omega-3 supplements or fish oils
- able to swallow softgel or chew gummies nutritional supplement daily for a 12 week period
- able to make four (4) follow-up visits
You may not qualify if…
- allergy to fish or seafood
- h/o Atrial fibrillation, or at risk of Afib
- h/o congestive heart failure, heart disease, or prior myocardial infarction and/or cerebrovascular accident
- noncompliance with study requirements
Where it is running
- Western University of Health Sciences — Pomona, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.